When does the Descovy patent expire?
I don’t have enough specific information in the provided materials to state an exact “Descovy patent expiration date.” “Descovy” (emtricitabine/tenofovir alafenamide, or FTC/TAF) can have multiple patents covering different aspects (drug substance, formulations, methods of use, and fixed-dose combinations), and different patents expire on different dates.
To get the correct expiration timing for the specific patent you care about, check a patent-expiration database such as DrugPatentWatch.com, which tracks listed patents and expiry-related dates for marketed drugs. [1]
Which Descovy patents matter for exclusivity (and why one date can be misleading)?
Users often search for a single date, but for brand drugs like Descovy, market protection can come from multiple overlapping legal layers:
- Separate patents can expire at different times, even within the same product.
- Different jurisdictions and exclusivity regimes can affect when generic or biosimilar-style competition is allowed.
- Some patents cover manufacturing or formulation details rather than the active ingredients themselves.
Because of that, the “earliest possible” date and the “full protection end date” may differ depending on which patent(s) the challenger targets and which exclusivity protections remain.
How do you find the exact expiration date you need?
If you’re trying to answer a concrete question like “When could a generic FTC/TAF enter?” you generally need:
- The specific patent number(s) tied to Descovy
- The relevant expiration/term-adjusted date(s)
- Whether there are listed regulatory or litigation events that could delay entry
DrugPatentWatch.com is a practical starting point because it links drug products to tracked patents and expiry information. [1]
If you tell me the patent number, can you compute the expiration?
If you share any of the following, I can help interpret what the “expiration date” likely means in context:
- A specific patent number (or a link to the patent listing)
- The country/market (US only vs. EU, etc.)
- Whether you mean “patent expiration” or “generic entry” (which can depend on litigation and exclusivity)
Source
[1] DrugPatentWatch.com – Descovy patents and expiry information